Articles

  • 3 days ago | ajmc.com | Giuliana Grossi

    The White House has proposed a sweeping reorganization and funding reduction for HHS in its fiscal year 2026 budget request, prompting alarm among public health experts, researchers, and lawmakers across the political spectrum.1,2A cornerstone of the proposal entails redirecting $14 billion toward a newly created agency—the Administration for a Healthy America—which will lead the Make America Healthy Again (MAHA) initiatives introduced by HHS Secretary Robert F.

  • 4 days ago | ajmc.com | Giuliana Grossi

    The FDA has approved darolutamide (Nubeqa; Bayer Healthcare Pharmaceuticals) for the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC), expanding its use beyond previously approved indications.1 This approval is supported by data from the phase 3 ARANOTE trial (NCT04736199), which demonstrated a significant improvement in radiographic progression-free survival (rPFS) for patients treated with darolutamide in combination with androgen deprivation therapy (ADT)...

  • 4 days ago | ajmc.com | Giuliana Grossi

    HHS Secretary Robert F. Kennedy, Jr, announced that the CDC will no longer recommend routine COVID-19 vaccines for healthy children and pregnant women, a move supported by leaders of the FDA and National Institutes of Health (NIH). However, the CDC’s website still lists COVID-19 vaccination as recommended for these groups, citing studies that show vaccination during pregnancy can protect both mother and infant from severe illness.

  • 5 days ago | ajmc.com | Giuliana Grossi

    The COVID-19 pandemic forced scientists and policymakers to make life-or-death decisions with limited and rapidly evolving data—a process likened to “flying the plane while building it,” in a new commentary published in Annals of Internal Medicine. The authors, from the American College of Physicians (ACP), called for humility, transparency, and more thoughtful, inclusive strategies moving forward to restore public trust and better prepare for future health crises.

  • 5 days ago | ajmc.com | Giuliana Grossi

    Persistent racial and age disparities in ovarian cancer mortality were demonstrated in a pair of abstracts presented ahead of the 2025 American Society of Clinical Oncology Annual Meeting, with particular attention to overlooked differences within Asian American, Native Hawaiian, and Pacific Islander (AANHPI) populations.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
200
Tweets
487
DMs Open
No
Giuliana Grossi
Giuliana Grossi @GiulianaGrossi
5 Mar 25

RT @Rep_Stansbury: This is not normal. https://t.co/KBXUGcFS90

Giuliana Grossi
Giuliana Grossi @GiulianaGrossi
4 Mar 25

RT @rasjbaraka: We collected over 11,000 signatures for nomination. I’m grateful for every single one. Let’s Reimagine New Jersey as a plac…

Giuliana Grossi
Giuliana Grossi @GiulianaGrossi
23 Feb 25

"Health care policy determined by ideology is nothing short of dangerous," @rtoddivey says. Abortion in 2025: Access, Fertility, and Infant Mortality Updates https://t.co/9ohtRYP74U #obgyn #healthpolicy